PROVOST FELLOWS has a total of 15 patent applications. Its first patent ever was published in 1990. It filed its patents most often in Australia, Canada and Ireland. Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are UNIV NEBRASKA, KING FAISAL SPECIALIST HOSPITAL & RES CENTRE and MAYO FOUNDATION.
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement | |
#4 | Medical technology | |
#5 | Computer technology | |
#6 | Control | |
#7 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Microorganisms | |
#4 | Analysing materials | |
#5 | Therapeutic chemical compounds | |
#6 | Electric digital data processing | |
#7 | Diagnosis and surgery | |
#8 | Heterocyclic compounds | |
#9 | Implantable devices | |
#10 | Teaching materials |
# | Name | Total Patents |
---|---|---|
#1 | Zisterer Daniela M | 2 |
#2 | Campiani Giuseppe | 2 |
#3 | Doyle John Martin | 2 |
#4 | Nacci Vito | 2 |
#5 | Williams David Clive | 2 |
#6 | Humphries Peter | 2 |
#7 | Hobson Hazel Audrey | 2 |
#8 | Farrar Gwenyth Jane | 2 |
#9 | Kenna Paul Francis | 2 |
#10 | Sullivan Dermot Joseph | 1 |
Publication | Filing date | Title |
---|---|---|
AU4677501A | A laser diode | |
AU3843899A | Apoptosis-inducing compounds | |
AU2300797A | Genetic suppression and replacement | |
AU7089696A | Strategy for suppressing the expression of an endogeneous gene by using compounds that are able to bind to the non-coding regions of the gene to be suppressed | |
AU7143996A | Method for the diagnosis of coeliac disease | |
IES73217B2 | Method for the quantitative measurement of human acute phase serum amyloid A protein | |
AU6235190A | Improvements in and relating to stable memory circuits |